Intravenous cyproheptadine hydrochloride in the treatment of pulmonary embolism: an experimental study.
D000818:Animals; D001779:Blood Coagulation Factors; D001792:Blood Platelets / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002309:Cardiology / Q000295:instrumentation; D002449:Cell Aggregation / Q000187:drug effects; D003533:Cyproheptadine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D006973:Hypertension / Q000139:chemically induced; D006976:Hypertension, Pulmonary / Q000139:chemically induced; D008168:Lung; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000209:etiology; D012701:Serotonin / Q000494:pharmacology; D013997:Time Factors; D014020:Tissue Extracts / Q000494:pharmacology
D001779:Blood Coagulation Factors; D014020:Tissue Extracts; D003533:Cyproheptadine; D012701:Serotonin